Dr. Kyle Jones completed his BS in Microbiology, Immunology, and Molecular Genetics at UCLA. He then completed his DDS and PhD degrees at the UCSF School of Dentistry. Dr. Jones’s PhD work was performed under the supervision of Dr. Ophir Klein and focused on the identification and characterization of oral epithelial stem cells. He also completed sub-specialty training in oral and maxillofacial pathology at UCSF under the direction of Dr. Richard Jordan. He is currently an Assistant Professor in the Department of Orofacial Sciences and Director of the UCSF Oral Dysplasia Program, where he manages patients with oral dysplasia in the UCSF Helen Diller Family Comprehensive Cancer Center. Dr. Jones is currently supported by a K23 career development award funded by the NIDCR and is a postdoctoral researcher in the laboratory of Dr. Matthew Spitzer. His work focuses on understanding how the immune microenvironment is altered in oral dysplasia prior to malignant transformation as well as in the setting of head and neck squamous cell carcinoma before and after immune checkpoint inhibitor therapy. Dr. Jones is also interested in defining and correlating the clinical, genetic, epigenetic, and transcriptional features of oral dysplastic lesions.